LOMIDE Eye drops, solution Ref.[50540] Active ingredients: Lodoxamide

Source: Medicines and Medical Devices Safety Authority (NZ) Revision Year: 2020 Publisher: Novartis New Zealand Limited, PO Box 99102, Newmarket, Auckland 1149, New Zealand

Product name and form

LOMIDE – Lodoxamide trometamol 0.1% Eye Drops.

Pharmaceutical Form
Sterile preserved eye drops, solution.

Qualitative and quantitative composition

Each mL of Lomide Eye Drops contains the active ingredient lodoxamide trometamol 0.178%w/v equivalent to lodoxamide 0.1%.

Excipient with known effect: Benzalkonium chloride 0.007% as a preservative.

For the full list of excipients, see section 6.1.

Active Ingredient	Description
Lodoxamide	Lodoxamide is a mast cell stabiliser that inhibits the in vivo Type I immediate hypersensitivity reaction in animals and man.

List of Excipients
Mannitol Hypromellose Sodium citrate dihydrate Citric acid monohydrate Tyloxapol Disodium edetate dihydrate Benzalkonium chloride Hydrochloric acid Sodium hydroxide Purified water

Pack sizes and marketing

10 mL or 5 mL DROP-TAINER bottle dispenser.

Marketing authorization holder

Novartis New Zealand Limited, PO Box 99102, Newmarket, Auckland 1149, New Zealand

Marketing authorization dates and numbers

25 July 1996

Drugs

Drug	Countries
LOMIDE	New Zealand

Next: Usage >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.